Status:
ACTIVE_NOT_RECRUITING
Telescoping Nail in Osteogenesis Imperfecta
Lead Sponsor:
Al-Azhar University
Conditions:
Osteogenesis
Eligibility:
All Genders
3-12 years
Phase:
NA
Brief Summary
Osteogenesis Imperfecta (OI) is an autosomal dominant disorder that mainly affects the bones. Bones break easily. The severity may be mild to severe. OI includes a blue tinge to the sclera of the eye...
Detailed Description
Osteogenesis imperfecta (OI) is an autosomal dominant or recessive connective tissue disorder caused by the deficiency of Type I collagen production associated with the deficiency of collagen Type I a...
Eligibility Criteria
Inclusion
- Growing child (3-12 ys) Bony deformities with other symptoms and signs of OI
Exclusion
- Old age (post Physeal closure). Other causes of bone deformities rather than OI
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06591546
Start Date
August 1 2022
End Date
November 30 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Egypt
Asyut, Egypt